TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2014

Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine.

Kimberly Y Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.